TY - JOUR
T1 - A process for assessing products for infection prevention in health care settings
T2 - A framework from the healthcare infection control practices advisory committee of the centers for disease control and prevention
AU - Chopra, Vineet
AU - Janssen, Lynn
AU - Bryant, Kristina
AU - Fauerbach, Loretta
AU - Talbot, Thomas R.
AU - Babcock, Hillary M.
N1 - Publisher Copyright:
© 2019 American College of Physicians.
PY - 2020/1/7
Y1 - 2020/1/7
N2 - Infection control is a complex task that spans people, products, and practices in diverse settings. For years, the Healthcare Infection Control Practices Advisory Committee (HICPAC) has provided advice and guidance to the Centers for Disease Control and Prevention (CDC) on how best to prevent infections. These recommendations have focused largely on health care delivery practices and occasionally on general categories of products. With an influx of novel infection control products and growing use of these products by frontline clinicians, an efficient process for developing transparent, rigorous product recommendations that includes myriad data sources was necessary. To address this gap, the CDC asked HICPAC to develop a process that would help inform committees considering product-related recommendations. This article describes the process to develop this approach and provides an outline of how the tool may be used when products with infection control claims are recommended in guidelines or recommendations for infection prevention.
AB - Infection control is a complex task that spans people, products, and practices in diverse settings. For years, the Healthcare Infection Control Practices Advisory Committee (HICPAC) has provided advice and guidance to the Centers for Disease Control and Prevention (CDC) on how best to prevent infections. These recommendations have focused largely on health care delivery practices and occasionally on general categories of products. With an influx of novel infection control products and growing use of these products by frontline clinicians, an efficient process for developing transparent, rigorous product recommendations that includes myriad data sources was necessary. To address this gap, the CDC asked HICPAC to develop a process that would help inform committees considering product-related recommendations. This article describes the process to develop this approach and provides an outline of how the tool may be used when products with infection control claims are recommended in guidelines or recommendations for infection prevention.
UR - http://www.scopus.com/inward/record.url?scp=85077930281&partnerID=8YFLogxK
U2 - 10.7326/M19-2172
DO - 10.7326/M19-2172
M3 - Article
C2 - 31739344
AN - SCOPUS:85077930281
SN - 0003-4819
VL - 172
SP - 30
EP - 34
JO - Annals of internal medicine
JF - Annals of internal medicine
IS - 1
ER -